Hyperactivation of ATM upon DNA-PKcs inhibition modulates p53 dynamics and cell fate in response to DNA damage

Ana Finzel1, Andrea Grybowski1, Jette Strasen1

  • 1Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.

Insights

A functional DNA damage response is essential for maintaining genome integrity. This study reveals how DNA-PKcs loss hyperactivates ATM, amplifying the p53 response and sensitizing cells to DNA damage-induced senescence.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • A functional DNA damage response (DDR) is crucial for maintaining genome integrity against DNA double-strand breaks.
  • The kinases ATM, ATR, and DNA-PKcs coordinate DNA repair and signal transduction to p53, influencing cell cycle arrest, apoptosis, or senescence.
  • The precise interplay between these kinases in orchestrating the DDR remains incompletely understood.

Purpose of the Study:

  • To systematically characterize the contribution of ATM, ATR, and DNA-PKcs in regulating p53 activity during the DNA damage response.
  • To elucidate the coordinated action of these kinases in ensuring faithful processing of DNA damage signals.
  • To investigate the functional consequences of disrupting the interplay between these kinases.

Main Methods:

  • Utilized specific kinase inhibitors to target ATM, ATR, and DNA-PKcs.
  • Employed quantitative analysis at the single-cell level to assess kinase contributions.
  • Investigated the impact on p53 activity and downstream cellular responses like senescence.

Main Results:

  • Identified a novel regulatory interplay between DNA-PKcs and ATM.
  • Demonstrated that loss of DNA-PKcs function leads to ATM hyperactivation.
  • Observed amplified p53 response and increased sensitivity to DNA damage-induced senescence upon DNA-PKcs inhibition.

Conclusions:

  • The findings reveal a critical regulatory mechanism where DNA-PKcs influences ATM activity and the subsequent p53-mediated cellular outcome.
  • This interplay is p53-dependent and dictates the efficacy of combined treatment strategies involving irradiation and DNA-PKcs inhibitors.
  • Highlights the importance of understanding kinase crosstalk for targeted cancer therapies.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K